Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07111663

An Observational Study of Individuals With Isolated Dystonia

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Vima Therapeutics · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.

Detailed description

The primary goal of this observational study is to further characterize and quantify disease severity and impact (including change over time) in individuals with either segmental, multifocal, or generalized dystonia in a structured manner, utilizing and comparing various well-known scales. In addition, medication history and any intercurrent events related to the participant's health (such as, but not limited to, hospitalizations, new diagnoses, etc.) will be captured. This study will provide standardized data to support planned future interventional clinical studies in this patient population and will provide a greater understanding of the population under study and the performance of clinical ratings scales.

Conditions

Timeline

Start date
2025-06-17
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2025-08-08
Last updated
2026-03-31

Locations

29 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07111663. Inclusion in this directory is not an endorsement.